Cellular and humoral immune responses and protection against schistosomes induced by a radiation-attenuated vaccine in chimpanzees

被引:57
作者
Eberl, M
Langermans, JAM
Frost, PA
Vervenne, RA
van Dam, GJ
Deelder, AM
Thomas, AW
Coulson, PS
Wilson, RA
机构
[1] Univ York, Dept Biol, York YO10 5YW, N Yorkshire, England
[2] Biomed Primate Res Ctr, Dept Parasitol, NL-2280 GH Rijswijk, Netherlands
[3] Biomed Primate Res Ctr, Dept Anim Sci, NL-2280 GH Rijswijk, Netherlands
[4] Leiden Univ, Med Ctr, Dept Parasitol, NL-2300 RC Leiden, Netherlands
关键词
D O I
10.1128/IAI.69.9.5352-5362.2001
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The radiation-attenuated Schistosoma mansoni vaccine is highly effective in rodents and primates but has never been tested in humans, primarily for safety reasons. To strengthen its status as a paradigm for a human recombinant antigen vaccine, we have undertaken a small-scale vaccination and challenge experiment in chimpanzees (Pan troglodytes). Immunological, clinical, and parasitological parameters were measured in three animals after multiple vaccinations, together with three controls, during the acute and chronic stages of challenge infection up to chemotherapeutic cure. Vaccination induced a strong in vitro proliferative response and early gamma interferon production, but type 2 cytokines were dominant by the time of challenge. The controls showed little response to challenge infection before the acute stage of the disease, initiated by egg deposition. In contrast, the responses of vaccinated animals were muted throughout the challenge period. Vaccination also induced parasite-specific immunoglobulin M (IgM) and IgG, which reached high levels at the time of challenge, while in control animals levels did not rise markedly before egg deposition. The protective effects of vaccination were manifested as an amelioration of acute disease and overall morbidity, revealed by differences in gamma-glutamyl transferase level, leukocytosis, eosinophilia, and hematocrit. Moreover, vaccinated chimpanzees had a 46% lower level of circulating cathodic antigen and a 38% reduction in fecal egg output, compared to controls, during the chronic phase of infection.
引用
收藏
页码:5352 / 5362
页数:11
相关论文
共 70 条
  • [1] ABE K, 1993, J MED PRIMATOL, V22, P237
  • [2] Age-dependent reduction of schistosome fecundity in Schistosoma haematobium but not Schistosoma mansoni infections in humans
    Agnew, A
    Fulford, AJC
    Mwanje, MT
    Gachuhi, K
    Gutsmann, V
    Krijger, FW
    Sturrock, RF
    Vennervald, BJ
    Ouma, JH
    Butterworth, AE
    Deelder, AM
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1996, 55 (03) : 338 - 343
  • [3] ANTIBODY TO CARBOHYDRATE AND POLYPEPTIDE EPITOPES ON THE SURFACE OF SCHISTOSOMULA OF SCHISTOSOMA-MANSONI IN EGYPTIAN PATIENTS WITH ACUTE AND CHRONIC SCHISTOSOMIASIS
    ALI, PO
    MANSOUR, M
    WOODY, JN
    SMITHERS, SR
    SIMPSON, AJG
    [J]. PARASITOLOGY, 1989, 98 : 417 - 424
  • [4] [Anonymous], 1981, Statistical Tables
  • [5] Aranda-Michel J, 1998, Gastroenterologist, V6, P34
  • [6] Evidence of a T helper type 2 activation in human schistosomiasis
    Araujo, MI
    deJesus, AR
    Bacellar, O
    Sabin, E
    Pearce, E
    Carvalho, EM
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (06) : 1399 - 1403
  • [7] Ashton PD, 2001, PARASITOLOGY, V122, P329, DOI 10.1017/S0031182001007351
  • [8] Schistosomiasis vaccines: Research to development
    Bergquist, NR
    Colley, DG
    [J]. PARASITOLOGY TODAY, 1998, 14 (03): : 99 - 104
  • [9] BUTTERWORTH AE, 1994, TROP GEOGR MED, V46, P197
  • [10] LONGITUDINAL-STUDIES ON HUMAN SCHISTOSOMIASIS
    BUTTERWORTH, AE
    FULFORD, AJC
    DUNNE, DW
    OUMA, JH
    STURROCK, RF
    [J]. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY OF LONDON SERIES B-BIOLOGICAL SCIENCES, 1988, 321 (1207) : 495 - 511